Results 191 to 200 of about 95,020 (310)

A Clinical Pharmacological Perspective on Intraperitoneal Chemotherapy. [PDF]

Drugs
Rietveld PCS, Guchelaar NAD, Sassen SDT, Koch BCP, Mathijssen RHJ, Koolen SLW.   +5 more
europepmc   +1 more source

Stabilised Hyaluronic Acid Gel Rectal Spacers in MRI‐Guided Brachytherapy for Gynaecological Cancers: A Prospective Feasibility Study

Journal of Medical Radiation Sciences, EarlyView.
This prospective study investigated the feasibility of stabilised hyaluronic acid gel as a rectal spacer in gynaecological cancer brachytherapy. In twelve patients, the spacer was successfully inserted into the rectovaginal space without serious adverse events, had high visibility on MRI, increased the target‐to‐rectum distance compared with no spacer ...
Carminia Lapuz, Sylvia Hanna, Eddie Lau, Adeline Lim, Mark Tacey, Daryl Lim Joon, Claire Dempsey, Jenny Sim, Michael Chao   +8 more
wiley   +1 more source

Peritoneal carcinomatosis management through cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: first experience in Iraq. [PDF]

Front Oncol
Mahmood AS, Al-Obaidi AD, Al-Obaidi MN, Madlul YA, Al Sakini AS, Hashim HT, Shakir AA, Qassim T, Ahmed Shimal A, Ahmed MJ, Mohammed FEA, Al-Obaidi H.   +11 more
europepmc   +1 more source

Guidelines for replacement of a balloon gastrostomy tube in infants and pediatric patients: The American Society for Parenteral and Enteral Nutrition

Journal of Parenteral and Enteral Nutrition, EarlyView.
Abstract Background Balloon gastrostomy tube (BGT) placements are increasing due to their ability to facilitate care of medically complex children. Management for routine and nonroutine tube replacement, including verification of proper replacement, lacks standardization, varying widely among different institutions and settings.
Beth Lyman, Loren Berman, Kathleen Carr, Cailin Frank, Peggi Guenter, Rachel Kassel, Janet Kimble, Carol McGinnis, Silvana Oppedisano, Elizabeth A. Paton, Gina Rempel, Derek S. Wakeman, David D. Church, Jacob T. Mey, Sarah Peterson, Liam McKeever   +15 more
wiley   +1 more source

The Role of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal GIST-Induced Sarcomatosis (GISTosis). [PDF]

J Clin Med
Spiliotis J, Kopanakis N, Rogdakis A, Peppas G, Fotiadou A, Evangelou K, Vassos N.   +6 more
europepmc   +1 more source

The Negative Impact of a Non‐Therapeutic Laparotomy in Patients With Inoperable Colorectal Peritoneal Metastases

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background The peritoneum is the third most prevalent location for metastases of colorectal cancer. In patients with resectable disease, cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS‐HIPEC) is the preferred treatment in the Netherlands, achieving median overall survival (OS) of 36–42 months. However, during
Teun van den Heuvel, Lars van Kesteren, Simon Nienhuijs, Pim Burger, Tineke Buffart, Jurriaan Tuynman, Ignace De Hingh   +6 more
wiley   +1 more source

Efficacy and safety of sequential hyperthermic intraperitoneal chemotherapy following surgery for pathological T staging 4 gastric cancer. [PDF]

World J Gastroenterol
Lian WL, Cai LS, Lian MQ, Lian MJ, Sun YQ, Lv CB, Huang GP, Huang RJ, Zhang YB, Zeng WM, Xu QH, Zhu QJ, Chen QX.   +12 more
europepmc   +1 more source

Inflammatory Markers may Determine Postoperative Complications in Cases of Peritoneal Carcinomatosis of Ovarian Origin Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives This study aimed to evaluate the ability of perioperative inflammatory markers to discriminate postoperative complications within 6 months in patients with ovarian cancer–related peritoneal metastasis undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Donmez Mustafa, Bisgin Tayfun, Manoglu Berke, Sokmen Selman, Sensoy Basoglu Ecem, Boztas Nilay, Ozgul Ozkardesler Sevda   +6 more
wiley   +1 more source

Quality of life following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a Canadian experience. [PDF]

Can J Surg
Taqi K, Stockley C, Fyfe A, Temple W, Mack L, Bouchard-Fortier A.   +5 more
europepmc   +1 more source

MiR‐145‐5p Attenuates Doxorubicin‐Induced Heart Injury Through Targeting Cardiomyocyte Pyroptosis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Doxorubicin (DOX), a potent anthracycline chemotherapeutic, exhibits dose‐dependent cardiotoxicity that limits its clinical utility. Although miR‐145‐5p demonstrates cardioprotective properties in cardiovascular diseases, its role in DOX‐induced cardiomyopathy remains undefined.
Xing‐Tao Chen, Yong‐Hong Yu, Yan‐Hua Du, Lin Xu, Xiang‐Ping Meng   +4 more
wiley   +1 more source